المؤلفون: Stuurman AL; Pallas health research and consultancy BV, Rotterdam, The Netherlands., Vonk Noordegraaf-Schouten M; Pallas health research and consultancy BV, Rotterdam, The Netherlands., van Kessel F; Pallas health research and consultancy BV, Rotterdam, The Netherlands., Oordt-Speets AM; Pallas health research and consultancy BV, Rotterdam, The Netherlands., Sandgren A; European Centre for Disease Prevention and Control (ECDC), Tomtebodavägen 11a, Solna, 171 65, Sweden., van der Werf MJ; European Centre for Disease Prevention and Control (ECDC), Tomtebodavägen 11a, Solna, 171 65, Sweden. marieke.vanderwerf@ecdc.europa.eu.

المصدر: BMC infectious diseases [BMC Infect Dis] 2016 Jun 08; Vol. 16, pp. 257. Date of Electronic Publication: 2016 Jun 08.

نوع المنشور: Journal Article; Review; Systematic Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Patient Compliance*, Antitubercular Agents/*therapeutic use , Latent Tuberculosis/*drug therapy, Antitubercular Agents/administration & dosage ; Directly Observed Therapy ; Humans ; Latent Tuberculosis/prevention & control ; Motivation ; Prospective Studies

المؤلفون: Sandgren A; Former Surveillance and Response Section, European Centre for Disease Prevention and Control (ECDC), Stockholm, 171 65, Sweden., Vonk Noordegraaf-Schouten M; Pallas, Health Research and Consultancy B.V., Rotterdam, 3001, The Netherlands., van Kessel F; Pallas, Health Research and Consultancy B.V., Rotterdam, 3001, The Netherlands., Stuurman A; Pallas, Health Research and Consultancy B.V., Rotterdam, 3001, The Netherlands., Oordt-Speets A; Pallas, Health Research and Consultancy B.V., Rotterdam, 3001, The Netherlands., van der Werf MJ; Tomtebodavägen 11a, 171 65, Solna, Sweden. marieke.vanderwerf@ecdc.europa.eu.

المصدر: BMC infectious diseases [BMC Infect Dis] 2016 May 17; Vol. 16, pp. 204. Date of Electronic Publication: 2016 May 17.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Latent Tuberculosis/*drug therapy, Emigrants and Immigrants ; HIV Infections/microbiology ; Health Personnel ; Ill-Housed Persons ; Humans ; Latent Tuberculosis/diagnosis ; Medication Adherence/statistics & numerical data

المؤلفون: Getahun H; The Global TB Programme, World Health Organization, Geneva, Switzerland getahunh@who.int., Matteelli A; The Global TB Programme, World Health Organization, Geneva, Switzerland., Abubakar I; Dept of Infection and Population Health, University College London, London, UK Public Health England, London, UK., Aziz MA; World Health Organization, Regional Office for Eastern Mediterranean, Egypt., Baddeley A; The Global TB Programme, World Health Organization, Geneva, Switzerland., Barreira D; National TB Programme, Ministry of Health, Brasilia, Brazil., Den Boon S; Independent consultant, Switzerland., Borroto Gutierrez SM; Pedro Kourí Institute of Tropical Medicine, La Habana, Cuba., Bruchfeld J; Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden., Burhan E; Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, Indonesia., Cavalcante S; Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, Brazil., Cedillos R; Hospital Nacionale Rosales, San Salvador, El Salvador., Chaisson R; Center for TB Research, John Hopkins University, Baltimore, MD, USA., Chee CB; Tan Tock Seng Hospital, Singapore., Chesire L; TB Advocacy Consortium, Nairobi, Kenya., Corbett E; London School of Hygiene and Tropical Medicine, Blantyre, Malawi., Dara M; World Health Organization, Regional Office for Europe, Denmark., Denholm J; Victorian Tuberculosis Program, Melbourne, Australia., de Vries G; KNCV Tuberculosis Foundation, Den Haag, The Netherlands., Falzon D; The Global TB Programme, World Health Organization, Geneva, Switzerland., Ford N; Dept of HIV and Global Hepatitis Programme, World Health Organization, Switzerland., Gale-Rowe M; Public Health Agency of Canada, Ottawa, ON, Canada., Gilpin C; The Global TB Programme, World Health Organization, Geneva, Switzerland., Girardi E; Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, Italy., Go UY; Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of Korea., Govindasamy D; Health Systems Research Unit, South African Medical Research Council, South Africa., D Grant A; Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK., Grzemska M; The Global TB Programme, World Health Organization, Geneva, Switzerland., Harris R; Public Health England, London, UK., Horsburgh CR Jr; Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USA., Ismayilov A; Main Medical Department, Ministry of Justice, Azerbaijan., Jaramillo E; The Global TB Programme, World Health Organization, Geneva, Switzerland., Kik S; McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada., Kranzer K; Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK., Lienhardt C; The Global TB Programme, World Health Organization, Geneva, Switzerland., LoBue P; Centers for Disease Control and Prevention, USA., Lönnroth K; The Global TB Programme, World Health Organization, Geneva, Switzerland Dept of Public Health Sciences, Karolinska Institute, Solna, Sweden., Marks G; Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, Australia., Menzies D; McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada., Migliori GB; WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy., Mosca D; Migration Health Department, International Organization of Migration, Geneva, Switzerland., Mukadi YD; Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USA., Mwinga A; Zambart Project, Lusaka, Zambia., Nelson L; Dept of HIV and Global Hepatitis Programme, World Health Organization, Switzerland., Nishikiori N; World Health Organization, Regional Office for the Western Pacific, Philippines., Oordt-Speets A; Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands., Rangaka MX; Dept of Infection and Population Health, University College London, London, UK Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Reis A; Knowledge, Ethics and Research Department, World Health Organization, Switzerland., Rotz L; Centers for Disease Control and Prevention, USA., Sandgren A; European Centre for Disease Prevention and Control, Stockholm, Sweden., Sañé Schepisi M; Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, Italy., Schünemann HJ; Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, Canada., Sharma SK; Knowledge, Ethics and Research Department, World Health Organization, Switzerland., Sotgiu G; European Centre for Disease Prevention and Control, Stockholm, Sweden., Stagg HR; Dept of Infection and Population Health, University College London, London, UK., Sterling TR; Vanderbilt University School of Medicine, Nashville, TN, USA., Tayeb T; National TB Programme, Ministry of Health, Riyadh, Saudi Arabia., Uplekar M; The Global TB Programme, World Health Organization, Geneva, Switzerland., van der Werf MJ; European Centre for Disease Prevention and Control, Stockholm, Sweden., Vandevelde W; European AIDS Treatment Group, Brussels, Belgium., van Kessel F; Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands., van't Hoog A; Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The Netherlands., Varma JK; Centers for Disease Control and Prevention, USA., Vezhnina N; HIV/TB and Penal System Projects, Russian Federation., Voniatis C; Clinical Laboratories, Ministry of Health, Nicosia, Cyprus., Vonk Noordegraaf-Schouten M; Pallas Health Research and Consultancy BV, Rotterdam, The Netherlands., Weil D; The Global TB Programme, World Health Organization, Geneva, Switzerland., Weyer K; The Global TB Programme, World Health Organization, Geneva, Switzerland., Wilkinson RJ; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UK., Yoshiyama T; Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, Japan., Zellweger JP; Tuberculosis Competence Centre, Berne, Switzerland., Raviglione M; The Global TB Programme, World Health Organization, Geneva, Switzerland.

المصدر: The European respiratory journal [Eur Respir J] 2015 Dec; Vol. 46 (6), pp. 1563-76. Date of Electronic Publication: 2015 Sep 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*therapeutic use , Isoniazid/*therapeutic use , Latent Tuberculosis/*drug therapy , Rifampin/*analogs & derivatives , Rifampin/*therapeutic use, Antirheumatic Agents/therapeutic use ; Coinfection/epidemiology ; Comorbidity ; Disease Management ; Drug Users ; Emigrants and Immigrants ; Evidence-Based Medicine ; HIV Infections/epidemiology ; Health Personnel ; Ill-Housed Persons ; Humans ; Interferon-gamma Release Tests ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/therapy ; Latent Tuberculosis/diagnosis ; Latent Tuberculosis/epidemiology ; Mass Screening ; Practice Guidelines as Topic ; Prisoners ; Public Health ; Radiography, Thoracic ; Renal Dialysis ; Risk Assessment ; Silicosis/epidemiology ; Substance-Related Disorders/epidemiology ; Transplant Recipients ; Tuberculin Test ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; World Health Organization

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.